Bionomics Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bionomics Limited generated cash of -$14,680,777, which is less than the previous year. Cash used in financing activities reached the amount of $15,108,794 last year. Net change in cash is therefore $504,991.
Cash Flow
| 2013 | -10.05M | -688.66K | 15.73M |
|---|---|---|---|
| 2016 | -11.44M | 822.62K | 24.73M |
| 2017 | -1.10M | 733.17K | -1.59M |
| 2018 | -15.13M | 60.13K | 1.94M |
| 2019 | -10.93M | 138.76K | 3.05M |
| 2020 | -2.69M | -134.66K | -3.69M |
| 2021 | -5.65M | -60.14K | 23.66M |
| 2022 | -15.02M | 429.23K | 18.63M |
| 2023 | -14.21M | 319.38K | 3.70M |
| 2024 | -14.68M | 0 | 15.10M |
BNOX Cash Flow Statement (2013 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 12.18M | 23.17M | 21.37M | 3.15M | 9.81M | 18.45M | 32.95M | 33.85M | 20.40M | 17.33M |
Operating activities | ||||||||||
Net income | -15.49M | -21.21M | -15.02M | -6.52M | -4.91M | -7.27M | -18.56M | -5.18M | -12.36M | -10.00M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 662.99K | 770.60K | 765.95K | 1.27M | 1.49M | 1.00M | 1.23M | 1.33M | 1.44M | 1.24M |
Stock-based compensation expense | 814.80K | 1.90M | 2.82M | 1.30M | 55.35K | 0 | 0 | 387.09K | 297.92K | 0 |
| Deferred income tax benefit | 814.80K | 1.90M | 2.82M | 1.30M | 55.35K | 0 | 0 | 387.09K | 297.92K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 196.06K | 33.06K | -27.02K | 25.55K | -139.58K | -103.41K | 475.29K | 31.62K | -282.32K | 0 |
Inventories | 0 | -4.79M | 3.89M | 152.82K | -19.52K | -106.93K | -47.62K | 8.83K | -31.40K | 0 |
Accounts payable | 527.09K | 480.40K | 710.61K | -47.22K | 85.43K | -1.01M | 0 | -1.49M | 0 | 0 |
Cash generated by operating activities | -14.68M | -14.21M | -15.02M | -5.65M | -2.69M | -10.93M | -15.13M | -1.10M | -11.44M | -10.05M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -442.89K | -88.36K | -34.97K | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -4 | 0 | -1.06K | -1.1K | -5.31K | -69.45K | -360.81K | -190.23K | -146.53K | -172.67K |
Acquisitions Net | 0 | 0 | 126.97K | 26.58K | -498.50K | 9.96K | 0 | 0 | 0 | 256.27K |
Cash generated by investing activities | 0 | 319.38K | 429.23K | -60.14K | -134.66K | 138.76K | 60.13K | 733.17K | 822.62K | -688.66K |
Financing activities | ||||||||||
Common Stock Issued | 10.11M | 3.85M | 22.62M | 32.38M | 1.96M | 7.07M | 0 | 110.36K | 0 | 15.82M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -415.47K | -48.22K | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -119.84K | -8.89M | -5.71M | -3.73M | -114.41K | -1.70M | -601.94K | -183.82K |
Cash used in financing activities | 15.10M | 3.70M | 18.63M | 23.66M | -3.69M | 3.05M | 1.94M | -1.59M | 24.73M | 15.73M |
Net Change In Cash | 504.99K | -11.01M | 1.80M | 18.21M | -6.65M | -8.63M | -14.49M | -906.96K | 13.45M | 5.11M |
Cash at end of period | 12.68M | 12.15M | 23.17M | 21.37M | 3.15M | 9.81M | 18.45M | 32.95M | 33.85M | 22.45M |
| Data source | Data source | Data source |